In patients with FSGS, urinary excretion of IGFBP-3 correlates with disease activity, and urinary levels of IGFBP-3 appear to distinguish FSGS from minimal change disease [37]. This evidence concerns the gene IGFBP3 and focal segmental glomerulosclerosis.